Pharmacological Advances in Endocrine and Metabolic Therapy

Drug development for metabolic diseases is rapidly evolving. Novel molecules target glucose transporters, incretin hormones, and lipid pathways. Advances in delivery systems improve patient compliance and minimize side effects. Personalized pharmacogenomics is reshaping diabetes and obesity treatment. Integration of AI-driven models supports optimized drug discovery. This track highlights cutting-edge research in therapeutic innovation.

Therapeutic Developments:

  • Incretin-Based and SGLT2-Targeted Therapies
  • Pharmacogenomic Insights in Metabolic Medicine
  • Nanocarrier Systems for Hormone Delivery

    Related Conference of Pharmacological Advances in Endocrine and Metabolic Therapy

    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Pharmacological Advances in Endocrine and Metabolic Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in